Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and lowers the price target from $22 to $19.
Barclays Maintains Equal-Weight on Privia Health Gr, Lowers Price Target to $19
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.